Stocks in Asia-Pacific mostly rose in Monday trade, as investors in the region react to the approval of Pfizer’s Covid-19 vaccine.
In Japan, the Nikkei 225 gained 0.52% while the Topix index rose 0.92%.
The Bank of Japan’s quarterly tankan survey showed on Monday business sentiment in Japan improving in the three months to December. The headline index for big manufacturers’ sentiment improved to minus 10 as compared with minus 27 in September. A median market forecast had expected the figure to come in at minus 15.
Mainland Chinese stocks were higher by the afternoon: The Shanghai composite was 0.4% higher while the Shenzhen component advanced 0.548%. The Hang Seng index in Hong Kong, on the other hand, dipped 0.1%.
Over in South Korea, the Kospi hovered above the flatline. South Korea has been dealing with a recent resurgence in coronavirus infections, with the country reporting its largest daily caseload ever on Sunday.
Shares in Australia edged higher, with the S&P/ASX 200 up around 0.5%.
MSCI’s broadest index of Asia-Pacific shares outside Japan rose 0.15%.